X @Forbes
Forbesยท2025-08-13 21:30
Funding & Investment - Celine Halioua's company has secured $135 million in funding from prominent investors [1] Product Development & Regulatory Approval - The company is developing canine longevity pills [1] - The company anticipates receiving its first conditional approval from the FDA (Food and Drug Administration) next year [1] Industry Focus - The company's focus is on extending the lifespan of dogs [1]